IPC board member, Lluis Puig, MD, PhD, discusses how the outbreak of COVID-19 affects the management of psoriasis patients currently on — or about to begin — systemic therapy to control their disease.
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Stay informed Join the email list to receive the latest information on psoriasis meetings, manuscripts and research. SUBSCRIBE